ADVANCED SOFT-TISSUE SARCOMA
Clinical trials for ADVANCED SOFT-TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOFT-TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED SOFT-TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial offers hope for Tough-to-Treat sarcoma
Disease control OngoingThis study is testing whether adding a new drug called lurbinectedin to a standard chemotherapy (doxorubicin) works better than the standard drug alone for people with advanced leiomyosarcoma, a type of soft-tissue cancer. The first part of the study aims to find the safest dose …
Matched conditions: ADVANCED SOFT-TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 04, 2026 01:35 UTC
-
Scientists test novel drug duo in fight against Tough-to-Treat sarcomas
Disease control OngoingThis study is testing a new combination of two drugs, HDM201 and pazopanib, for people with advanced soft tissue sarcoma that has spread and stopped responding to standard chemotherapy. The first part aims to find the safest dose of the combination. The second part will gather ea…
Matched conditions: ADVANCED SOFT-TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC